CASSIPA Trademark
Trademark Overview
On Friday, April 29, 2022, a trademark application was filed for CASSIPA with the United States Patent and Trademark Office. The USPTO has given the CASSIPA trademark a serial number of 97388515. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, May 14, 2025. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The CASSIPA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations
General Information
| Serial Number | 97388515 |
| Word Mark | CASSIPA |
| Filing Date | Friday, April 29, 2022 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Wednesday, May 14, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 21, 2023 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 4, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
Trademark Events
| Event Date | Event Description |
| Thursday, February 16, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, May 3, 2022 | NEW APPLICATION ENTERED |
| Wednesday, May 4, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 15, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, March 1, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 21, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 21, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 16, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Saturday, November 18, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, April 30, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, April 30, 2024 | SOU EXTENSION 2 GRANTED |
| Thursday, November 16, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 16, 2023 | SOU EXTENSION 1 FILED |
| Thursday, November 16, 2023 | SOU EXTENSION 1 GRANTED |
| Tuesday, April 30, 2024 | SOU EXTENSION 2 FILED |
| Thursday, October 24, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, October 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, October 24, 2024 | SOU EXTENSION 3 FILED |
| Thursday, October 24, 2024 | SOU EXTENSION 3 GRANTED |
| Wednesday, May 14, 2025 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, May 14, 2025 | SOU EXTENSION 4 FILED |
| Wednesday, May 14, 2025 | SOU EXTENSION 4 GRANTED |
| Thursday, May 15, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 1, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
